Showing results (461-470 of 4,041) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.Pharmacoepidemiology and Drug Safety|April 18, 2013
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic controlAdriana M Hung, Christianne L Roumie, Robert A Greevy, et al.Pharmacoepidemiology and Drug Safety|May 23, 2013
Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia studyNicole Pratt, Morten Andersen, Ulf Bergman, et al.Pharmacoepidemiology and Drug Safety|May 3, 2013
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009Maryam M Asgari, Jashin J Wu, Joel M Gelfand, et al.Pharmacoepidemiology and Drug Safety|December 12, 2012
Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, ItalyJordi Castellsague, Federica Pisa, Valentina Rosolen, et al.Pharmacoepidemiology and Drug Safety|December 12, 2012
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement NetworkDavid Gaist, Mari-Ann Wallander, Antonio González-Pérez, et al.Pharmacoepidemiology and Drug Safety|January 22, 2013
Validation of an algorithm to estimate gestational age in electronic health plan databasesQian Li, Susan E Andrade, William O Cooper, et al.Pharmacoepidemiology and Drug Safety|January 3, 2013
A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medicationsAndrew T McAfee, Joan Landon, Meghan Jones, et al.Pharmacoepidemiology and Drug Safety|January 9, 2013
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapyChristina DeFilippo Mack, Robert J Glynn, M Alan Brookhart, et al.Pharmacoepidemiology and Drug Safety|January 16, 2013
High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009Benedikt Fischer, Wayne Jones, Jürgen RehmPageof 405